candesartan

angiotensin II receptor type 1 ; Canis lupus familiaris







8 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 20625108 Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker. 2010 Jul 27 1
2 16598165 Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters. 2006 Mar 1
3 16948800 Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system. 2006 Oct 1
4 15312214 Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs. 2004 Aug 1
5 12821247 Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. 2003 Jun 18 1
6 11374397 Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. 2001 Apr 27 1
7 11602819 Effects of angiotensin II type 1 receptor antagonist (candesartan) in preventing fatal ventricular arrhythmias in dogs during acute myocardial ischemia and reperfusion. 2001 Nov 1
8 28095238 Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor. 2001 Mar 1